Skip to content

May 6, 2026

Home
Signal News
Biopharma Brief
Week in Review
Contact

Light/Dark Button

Search for:

Home
M&A / Deals
MSD concludes Terns acquisition to expand CML pipeline

M&A / Deals

MSD concludes Terns acquisition to expand CML pipeline

Pharmaceutical Technology

MSD has completed its acquisition of Terns Pharmaceuticals, expanding its pipeline of treatments for chronic myeloid leukaemia (CML).

Read full story

pharminent May 6, 2026 (Last updated: May 6, 2026)

Pharmaceutical Technology

MSD has completed its acquisition of Terns Pharmaceuticals, expanding its pipeline of treatments for chronic myeloid leukaemia (CML).

Read full story

Post navigation

Previous: FDA Expands Market Access, Authorizes New ENDS Products

Next: MSD concludes Terns acquisition to expand CML pipeline

Related Stories

M&A / Deals

Bayer looks to uphold Eylea legacy with $2.45bn Perfuse buyout

pharminent May 6, 2026

M&A / Deals

CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026

pharminent May 6, 2026

M&A / Deals

GSK bolts on siRNA drug from China’s SiranBio in $1bn deal

pharminent May 6, 2026

You May Have Missed

Commercial

Novo hikes guidance on Wegovy pill’s fast sales start

pharminent May 6, 2026

M&A / Deals

Bayer looks to uphold Eylea legacy with $2.45bn Perfuse buyout

pharminent May 6, 2026

Regulatory

FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight

pharminent May 6, 2026

M&A / Deals

CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026

pharminent May 6, 2026

Copyright © 2026 All rights reserved. | ReviewNews by AF themes.